Winchester, MA, United States of America

Igor Splawski

This inventor holds 13 USPTO granted patents and 9 published patent applications and 4 EPO patents. Top assignee: Novartis Ag. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Igor Splawski. Retrieved from https://idiyas.com/inventor/igor-splawski-likpb1us

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 9)

% Patents Active = 84.6

EPO Patents = 4 (Patent Applications = 11)

Average Co-Inventor Count = 6.5

ph-index = 5

Forward Citations = 118(Granted Patents)

Location History:

Cambridge, MA (US) (2016 - 2018)
Winchester, MA (US) (2012 - 2024)

Company Filing History:

13 out of 3,977

Novartis Ag

patents

Years Active: 2012-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11878060 - mRNA-mediated immunization methods (2024-01-23),

2. 10870698 - Nucleic acids encoding lectin-like oxidized LDL receptor 1 antibodies (2020-12-22),

3. 10865237 - Nucleic acids encoding anti-Factor P antibodies (2020-12-15),

4. 10407496 - Compositions and methods for antibodies targeting complement protein C5 (2019-09-10),

5. 10385127 - Compositions and methods for antibodies targeting EPO (2019-08-20),

6. 10106605 - Compositions and methods for antibodies targeting Epo (2018-10-23),

7. 9988440 - Compositions comprising antibodies targeting factor P (2018-06-05),

8. 9982046 - Methods of treating cardiovascular disorders with lectin-like oxidized LDL receptor 1 antibodies (2018-05-29),

9. 9512222 - Lectin-like oxidized LDL receptor 1 antibodies and methods of use (2016-12-06),

10. 9365646 - Compositions and methods for antibodies targeting EPO (2016-06-14),

11. 9051365 - Antibodies that bind factor P (2015-06-09),

12. 8883158 - Compositions and methods for antibodies targeting complement protein C5 (2014-11-11),

13. 8241628 - Compositions and methods for antibodies targeting complement protein C5 (2012-08-14),

Title: Igor Splawski: Innovator in Immunization Technologies

Introduction

Igor Splawski is a prominent inventor based in Winchester, MA, known for his significant contributions to the field of immunization technologies. With a total of 13 patents to his name, he has made remarkable advancements in the development of methods that enhance immune responses.

Latest Patents

Among his latest patents, one focuses on mRNA-mediated immunization methods. This patent outlines innovative techniques for immunization and the generation of antibodies using compositions that include cationic lipids and polynucleotide molecules, such as mRNA, which code for immunogens. Another notable patent involves nucleic acids encoding lectin-like oxidized LDL receptor 1 antibodies. This invention pertains to monoclonal antibodies that bind to the human lectin-like oxidized LDL receptor 1, along with pharmaceutical compositions and treatment methods that utilize these antibodies.

Career Highlights

Igor Splawski has established a successful career in the pharmaceutical industry, particularly with Novartis AG, where he continues to contribute to groundbreaking research and development in immunology. His work has been instrumental in advancing therapeutic options for various diseases.

Collaborations

Throughout his career, Igor has collaborated with esteemed colleagues, including Michael Roguska and Yong-In Kim, to further enhance the impact of his research and innovations.

Conclusion

Igor Splawski's work in immunization technologies exemplifies the importance of innovation in the medical field. His patents and contributions continue to pave the way for new treatments and advancements in healthcare.

Profile summary based on public USPTO records.